At a glance
- Originator Novartis
- Class Antibacterials; Monosaccharides; Peptide antibiotics
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bacterial infections; Chemotherapy-induced damage
Most Recent Events
- 16 May 2001 No-Development-Reported for Chemotherapy induced damage (Prevention) in Austria (Parenteral)
- 16 May 2001 No-Development-Reported for Chemotherapy induced damage in Switzerland (Parenteral)
- 06 Jul 1998 No-Development-Reported for Bacterial infections in Austria (Parenteral)